Clinical Trial of Minimally Invasive Robotic Spine Surgery

March 29, 2020 updated by: Jin S. Yeom, Seoul National University Hospital

Randomized Comparative Trial of Minimally Invasive Robotic vs. Freehand in Short Adult Degenerative Spinal Fusion Surgeries

The purpose of this study was to quantify potential short- and long-term benefits of robotically-guided minimally invasive spine surgery in instrumentation of degenerative lumbar or lumbosacral spine disease in adult patients, in comparison to instrumentation in a matching cohort of control patients performed using conventional freehand technique.

Study Overview

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gyeonggi-do
      • Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707
        • Seoul National University Bundang Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult patients (age from 40 years to 85 years), undergoing short (below 3 consecutive vertebrae) lumbar or lumbosacral fixation surgery.
  • Primary surgery and revision surgery
  • Patient capable of complying with study requirements
  • Signed informed consent of patient or legal guardian

Exclusion Criteria:

  • Infection or malignancy
  • Primary abnormalities of bones (e.g. osteogenesis imperfecta)
  • Primary muscle diseases, such as muscular dystrophy
  • Neurologic diseases (e.g. Charcot-Marie Tooth, Guillain-Barre syndrome, cerebral palsy, neurofibroma)
  • Spinal cord abnormalities with any neurologic symptoms or signs
  • Spinal cord lesions requiring neurosurgical interventions, such as hydromyelia
  • Paraplegia
  • Patients requiring anterior release or instrumentation
  • Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study.
  • Patient cannot follow study protocol, for any reason
  • Patient (or legal guardian, when applicable) cannot or will not sign informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Robot assisted pedicle screw fixation
posterior lumbar interbody fusion using Robot assisted pedicle screw fixation (Renaissance, Mazor Robotics Ltd, Caesare, Israel)
Renaissance (Mazor Robotics Ltd, Caesare, Israel) is the name of the robot
Other Names:
  • (Renaissance, Mazor Robotics Ltd, Caesare, Israel)
Active Comparator: Free hand technique
using Free hand technique, posterior lumbar interbody fusion (No specific device)
No specific device is necessary in the "free hand technique"

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pedicle screw instrumentation accuracy
Time Frame: within 7 days after operation
The location of pedicle screw is evaluated by postoperative CTs in a subset of patients
within 7 days after operation
Oswestry Disability Index
Time Frame: up to 5 year after operation, every year
Health status
up to 5 year after operation, every year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fusion rates
Time Frame: up to 5 year after operation
This is assessed by postoperative computed tomography at 1 year after surgery
up to 5 year after operation
Operation duration
Time Frame: After operation
Intraoperative time
After operation
intraoperative blood loss
Time Frame: after operation
intraoperative blood loss
after operation
postoperative drainage
Time Frame: within 3 days after operation
Total drainage after surgery
within 3 days after operation
amount of transfusion
Time Frame: within 7 days after operation
Total transfusion during and after surgery
within 7 days after operation
time to ambulation
Time Frame: within 3 days after operation
immediate postop to ambulation start
within 3 days after operation
Change of Oswestry Disability Index
Time Frame: up to 5 year after surgery, every year
Health status
up to 5 year after surgery, every year
Visual Analog Pain Scale
Time Frame: up to 5 year after operation, every year
Pain status
up to 5 year after operation, every year
SF-36
Time Frame: up to 5 year after operation, every year
Health status
up to 5 year after operation, every year
Radiographic adjacent level degeneration
Time Frame: up to 5 year after operation, every year
Radiographic changes according to UCLA, vertebral body translation, motion change, segmental kyphosis or lordosis, disc height changes
up to 5 year after operation, every year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ho-Joong Kim, MD, Seoul National University Bundang Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2013

Primary Completion (Actual)

April 1, 2014

Study Completion (Actual)

December 1, 2019

Study Registration Dates

First Submitted

April 15, 2014

First Submitted That Met QC Criteria

April 19, 2014

First Posted (Estimate)

April 23, 2014

Study Record Updates

Last Update Posted (Actual)

March 31, 2020

Last Update Submitted That Met QC Criteria

March 29, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • Mazor_001

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Degenerative Lumbar Spinal Stenosis

Clinical Trials on Renaissance, Mazor Robotics Ltd, Caesare, Israel

3
Subscribe